Evidence map›Paper›PMID 42254004›Full record

ReviewFrontiers in immunology2026

Gut microbiota and its metabolites with thyroid diseases: functions and mechanisms.

Chao Jia, Min Li, Xianqiang Yu

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chao JiaDepartment of Critical Care Medicine, Qingdao Municipal Hospital (Qingdao Hospital of Rehabilitation University), Qingdao, China.
Min LiDepartment of Thyroid Disease Diagnosis and Treatment, Qingdao Municipal Hospital (Qingdao Hospital of Rehabilitation University), Qingdao, China.
Xianqiang YuDepartment of Thyroid Disease Diagnosis and Treatment, Qingdao Municipal Hospital (Qingdao Hospital of Rehabilitation University), Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota, a complex and dynamic ecosystem of microorganisms residing in the gastrointestinal tract, has emerged as a critical regulator of human physiology, extending its influence far beyond digestion. Recent advances have illuminated the existence of a bidirectional communication network known as the "gut-thyroid axis" which posits that the intestinal microbial community and its vast repertoire of bioactive metabolites are fundamental modulators of thyroid health and disease pathogenesis. This comprehensive academic review synthesizes current evidence to elucidate the multifaceted functions and mechanisms through which gut microbiota and its metabolites, such as short-chain fatty acids, secondary bile acids, and lipopolysaccharides, impact thyroid disorders. We detail how these microbial components regulate systemic immunity, influence thyroid hormone metabolism, maintain intestinal barrier integrity, and modulate nutrient absorption, thereby contributing to the development and progression of autoimmune thyroid diseases, thyroid dysfunction, and potentially thyroid cancer. Furthermore, the review discusses the translational implications of this knowledge, including the potential for microbiota-targeted interventions like probiotics, prebiotics, and dietary modifications as adjunctive strategies in thyroid disease management. By integrating findings from human studies and animal models, this review aims to provide a mechanistic framework for understanding the gut-thyroid connection and to highlight promising avenues for future research and precision medicine approaches in endocrinology.

Indexed as

Gastrointestinal MicrobiomeThyroid DiseasesThyroid GlandAnimalsFatty Acids, VolatileHumansIntestinal Barrier FunctionThyroid HormonesFatty Acids, VolatileThyroid Hormonesgut microbiotagut-thyroid axisHashimoto’s thyroiditisshort-chain fatty acids (SCFAs)thyroid cancerthyroid diseases

Identifiers

PMID42254004
PMCPMC13233261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.